Presentation is loading. Please wait.

Presentation is loading. Please wait.

Japanese Approach to colon cancer and the Outcome Dep. of Surgical Oncology Tokyo Medical and Dental University Kenichi Sugihara.

Similar presentations


Presentation on theme: "Japanese Approach to colon cancer and the Outcome Dep. of Surgical Oncology Tokyo Medical and Dental University Kenichi Sugihara."— Presentation transcript:

1 Japanese Approach to colon cancer and the Outcome Dep. of Surgical Oncology Tokyo Medical and Dental University Kenichi Sugihara

2 Overall Survival Colon Ca (n=3061) P = 0.0033 year Survival rate 012345678910 0.0 0.2 0.4 0.6 0.8 1.0 Rectal Ca (n=1393) 84.6% 80.6% 1997 〜 2000 in 18 hospitals median follow-up time: 71 months

3 OS; Stage II Colon Cancer N 5Y-OS 800, 93.5% 914, 88.8% 195, 81.7% 92, 82.1% 128, 91.3% 743, 77.4% 189, 55.5% P<0.0001 Stage I Stage IIA Stage IIB Stage IIC Stage IIIA Stage IIIB Stage IIIC year Survival rate 012345678910 0.0 0.2 0.4 0.6 0.8 1.0 TNM 7 th ed.

4 N 5Y-OS 800, 93.5% 914, 88.8% 195, 81.7% 92, 82.1% 128, 91.3% 743, 77.4% 189, 55.5% P<0.0001 Stage I Stage IIA Stage IIB Stage IIC Stage IIIA Stage IIIB Stage IIIC year Survival rate 012345678910 0.0 0.2 0.4 0.6 0.8 1.0 TNM 7 th ed. OS; Stage III Colon Cancer

5 Randomized Studies of Adjuvant Chemotherapy in Japan TrialsRegimenDuration (months) StageNo. of Pts Enrolment JCOG02055FU+l-LV vs. UFT+LV 6 Stage III Colon cancer 1101 completed in Nov. 2006 JCOG0910Capecitabine Vs. S-1 6 Stage III Colon cancer 1550 started in March 2010 ACTS-CCUFT+LV Vs. S-1 6 Stage III Colon cancer 1530 completed in June 2009 SACURAUFT vs. surgery alone 12Stage II Colon cancer 2024 completed in July 2010 ACTS-CC 02 UFT+LV vs. SOX 6 anyTN2 Colon cancer 1200 started in April 2010 ACTS-RCUFT vs. S-112Stage II, III Rectal cancer 961 completed in March 2009 JFMC37Capecitabine6 vs 12Stage III Colon cancer 1306 completed in Dec. 2009

6 UFT/LV vs. 5FU/LV JCOG 0205: Phase III non-inferiority study Stage III Colon Cancer (n=1,101) R UFT/LV (oral) (n=551) 5FU/LV (RPMI) (n=550) Primary endpoint : DFS Secondary endpoint : OS, Safety Feb. 2003 - Oct. 2006 78.3 % 75.0 % 73.8 % 90.3 % 94.2% 88.2 % Disease Free Survival Overall Survival

7 Mortality/Morbidity Surgery of Colon Cancer No. Mortality 118,426 0.7% rt. colectomy/hemicolectomy No. 39,386 Anastomotic Leakage 1.5% high anterior resection 17,4182.5% National Survey of Digestive Surgery by the Japanese Society of Gastroenterological Surgery 1,191,643 surgeries between 2006 and 2008 high/low anterior resection 55,557 0.34% APR 11908 0.7%

8 Differences of Colon Cancer Care between Japan and Western  Scope of LN dissection  Histopathological examination of resected specimens  Surveillance after surgery  Strategy for liver metastasis  Medical care system/Medical insurance system JSCCR 

9 Thank you for your attention


Download ppt "Japanese Approach to colon cancer and the Outcome Dep. of Surgical Oncology Tokyo Medical and Dental University Kenichi Sugihara."

Similar presentations


Ads by Google